Cited by

• 2022Improving resilience of the healthcare supply chain in a pandemic: Evidence from Europe during the COVID-19 crisis211 cited
• 2021A collaborative approach to maintaining optimal inventory and mitigating stockout risks during a pandemic: capabilities for enabling health-care supply chain resilience120 cited
• 2021Supply chain resilience for vaccines: review of modeling approaches in the context of the COVID-19 pandemic96 cited
• 2023Supply chain planning of vaccine and pharmaceutical clusters under uncertainty: The case of COVID-1976 cited
• 2023Interlinking organisational resources, AI adoption and omnichannel integration quality in Ghana’s healthcare supply chain72 cited
• 2021Evaluating Supply Chain Collaboration Barriers in Small- and Medium-Sized Enterprises60 cited
• 2021The Vaccine Supply Chain: A Call for Resilience Analytics to Support COVID-19 Vaccine Production and Distribution48 cited
• 2023Evaluation of sustainable cold chain suppliers using a combined multi-criteria group decision-making framework under fuzzy ZE-numbers48 cited
• 2022Lean and resilience in the healthcare supply chain – a scoping review46 cited
• 2025Evaluation and prioritization of artificial intelligence integrated block chain factors in healthcare supply chain: A hybrid Decision Making Approach44 cited
• 2023The role of power-based behaviours on pharmaceutical supply chain resilience43 cited
• 2024Prioritizing Performance Indicators for the Circular Economy Transition in Healthcare Supply Chains41 cited
• 2022Multiple criteria decision‐making in healthcare and pharmaceutical supply chain management: A state‐of‐the‐art review and implications for future research36 cited
• 2021Analyzing the impact of supply chain innovation as a mediator for healthcare firms' performance35 cited
• 2024On solving a healthcare supplier selection problem using MCDM methods in intuitionistic fuzzy environment35 cited
• 2022Vaccine supply chain: Resilience-by-design and resilience-by-intervention34 cited